Vagal Nerve Stimulator (VNS)
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
23 Jan 2024
Description
The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised. Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.
Scope
- Reference
- CAV-DCO (22-23) 147
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33158210
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—